Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.31158 | 12 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.2921 | 12 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.29323 | 12 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.24217 | 12 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.23317 | 11 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.34469 | 12 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.39967 | 15 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.26753 | 11 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.25508 | 11 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.27845 | 12 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.27731 | 12 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.26255 | 12 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.28503 | 12 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.27966 | 12 |